Perspectives on a new prescription omega-3 fatty acid, icosapent ethyl, for hypertriglyceridemia-Reference-Cited by-同舟云学术

Perspectives on a new prescription omega-3 fatty acid, icosapent ethyl, for hypertriglyceridemia

Published:2014-04-01 Issue:2 Volume:9 Page:149-161
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Jacobson Terry A¹

Affiliation:

1. Department of Medicine, Office of Health Promotion & Disease Prevention, Emory University, Emory Faculty Office Building, 49 Jesse Hill Jr. Dr. NE, Atlanta, GA 30345, USA Tel.: Fax:

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.14.10

Reference89 articles.

1. Miller M, Stone NJ, Ballantyne C et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123(20), 2292–2333 (2011).

2. Talayero BG, Sacks FM. The role of triglycerides in atherosclerosis. Curr. Cardiol. Rep. 13(6), 544–552 (2011).

3. Jacobson TA, Miller M, Schaefer EJ. Hypertriglyceridemia and cardiovascular risk reduction. Clin. Ther. 29(5), 763–777 (2007).

4. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82(2), 495–506 (1990).

5. Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH. Hypertriglyceridemia and its pharmacologic treatment among US adults. Arch. Intern. Med. 169(6), 572–578 (2009).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the Role of Icosapent Ethyl in Clinical Practice;American Journal of Cardiovascular Drugs;2020-03-11

2. Icosapent ethyl in hypertriglyceridaemia: a guide to its use;Drugs & Therapy Perspectives;2016-01-20

3. History and future of omega-3 fatty acids in cardiovascular disease;Current Medical Research and Opinion;2015-12-03

4. Icosapent Ethyl: A Review of Its Use in Severe Hypertriglyceridemia;American Journal of Cardiovascular Drugs;2014-11-27